drugset / Trial / NCT04641819
Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients
Phase 4
Unknown
1127 enrolled
ShuGuang Hospital
LinkDoc Technology (Beijing) Co. Ltd. · collabShaanxi Buchang Pharmaceutical Co., Ltd · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a nationwide, multicenter, randomized, prospective, real-world study. The purpose of this study is to evaluate the effect and safety of Yangzheng Compound Mixture in the treatment of sleep disorder in cancer patients with Qi-Yin deficiency syndrome during chemotherapy.
Timeline
- Start
- 2021-04-27
- Primary completion
- 2023-09-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yangzheng Compound Mixture | Traditional medicine (herbal / TCM) | 10 ml | — |